Please upgrade your browser

We built this website using the latest browser technologies to deliver the very best experience.

This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.

We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.

Download Microsoft EdgeDownload Microsoft Edge
DBm-Health app

Self-monitoring of blood glucose levels

DBm-Health

Self-monitoring of blood glucose levels

DBm-Health helps individuals monitor their blood glucose levels and share their readings with health care professionals.

It is ideally suited to patients needing additional support to maintain safe blood glucose levels.

The need for safe remote monitoring during the COVID-19 pandemic

The COVID-19 pandemic has increased the need for digital technologies to help clinicians maintain contact with their patients and view essential healthcare data remotely, while reducing the risk to individuals who are particularly vulnerable to COVID-19 and are advised to stay at home during the pandemic.

Free smartphone app

Free smartphone app

Patients can input and share blood glucose readings and notes, request a callback from their care team, and review previous readings.

Clinician's desktop app

Patient lists can be filtered, individual blood glucose readings viewed with other relevant data, and messages sent to patients.

Clinician's desktop app
Self-management for patients

Self-management for patients

Self-help guides and a diary record of blood glucose readings helps high-risk groups self-manage their condition.

DBm-Health can be used by anyone needing to take regular blood glucose readings, including:
  • Patients new to insulin treatment who are not able to effectively self-manage
  • Cancer patients receiving high dose steroid treatment
  • Type 2 diabetic patients transitioning to insulin treatment and requiring short-term intensive management
  • Women with diabetes planning a pregnancy
  • Type 1 diabetic patients not suited to continuous glucose monitoring (CGM)  
  • Type 2 diabetic patients in community settings  
  • Patients with coronavirus needing enhanced glycemic control  
  • Pre-diabetic patients requiring intensive support

Benefits

Increased patient contact
Patient communication

Daily viewing of readings and in-app messaging may facilitate increased patient-clinician communication

Increased service capacity
Increased service capacity

Complex cases may be dealt with quicker, freeing up capacity for more patients without increasing resources

Improved adherence
Improved adherence

Easy-to-use apps can lead to more comprehensive reporting of blood glucose levels

Improved reliability
Improved reliability

Replaces paper-based processes associated with poor data reliability

Faster audit
Faster audit

System reports replace time-consuming manual audit processes

Support for self-management
Support for self-monitoring

User-friendly displays of historical readings and self-help guides empower patients to self-monitoring their condition

Currently in development phase prior to commercial launch.

Note: Not all Sensyne Health products are available in all territories, for further information contact head office.

FAQs

What is DBm-Health?
Who is DBm-Health intended for?
How do patients access and use the app?
How does the system help diabetes services?
How will DBm-Health help the NHS during and after the pandemic?
What are the main features of the app?
How much does DBm-Health cost? 
Does DBm-Health store any patient sensitive data?
What is the background to the development of DBm-Health?
Is there evidence to support the use of digital technologies for the management of blood glucose levels?
Does DBm-Health provide a patient diagnosis? 
Who can see the data entered into DBm-Health? 
What does anonymised data mean?
How do you protect personal and healthcare data? 
Who can patients contact with questions about their data?

References

  1. 2019 surveillance of 4 diabetes guidelines – Consultation document. NICE https://www.nice.org.uk/guidance/ ng28/update/ng28-update-1/documents/surveillance-review-proposal

  2. Kebede MM, Zeeb H, Peters M, Heise TL, Pischke CR. Effectiveness of Digital Interventions for Improving Glycemic Control in Persons with Poorly Controlled Type 2 Diabetes: A Systematic Review, Meta-analysis, and Meta-regression Analysis. Diabetes Technol Ther. 2018;20(11):767-782. doi:10.1089/dia.2018.0216